在Hodgkin淋巴瘤的基线和临时FDG-PET扫描中,定量PET参数的预测效用
Natalia Kovaleva1, Shin Hnin Wai2, Niamh Waters2
1Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia.
Clinical lymphoma, myeloma & leukemia
|August 9, 2025
概括
定量PET参数,包括最大标准吸收值 (ΔSUVmax) 的变化,可能会改善经典霍奇金淋巴瘤 (cHL) 中的PET (iPET) 预测. 在 iPET 时,低于 72% 的 ΔSUVmax 独立预测了cHL 患者更差的无进展生存期 (PFS).
科学领域:
- 在瘤学瘤学.
- 核医学是一种核医学.
- 无线电学 (Radiomics) 是一种无线电学.
背景情况:
- 使用Deauville分数 (DS) 的临时正子发射断层扫描 (iPET) 对于指导经典霍奇金淋巴瘤 (cHL) 治疗至关重要.
- 像 ΔSUVmax, ΔTMTV 和 ΔTLG 这样的定量 PET 参数可能比 iPET 中的标准 DS 提供更好的预测值.
- 目前对cHL治疗反应的预测模型可以通过更精确的预后指标来改进.
研究的目的:
- 评估基线 (PET0) 和临时 (iPET) 的定量PET参数与cHL患者的生存结果的关联.
- 确定定量PET指标是否可以独立预测cHL中无进展生存率 (PFS).
- 将定量PET参数的预测能力与iPET的标准Deauville分数 (DS) 进行比较.
主要方法:
- 在2008年至2022年期间接受治疗的98名cHL患者的回顾性分析.
- 在基线和 iPET 中评估定量PET参数 (ΔSUVmax, ΔTMTV, ΔTLG).
- 统计分析将PET参数和DS与无进展生存率 (PFS) 相关联起来.
主要成果:
- 没有任何基线PET参数与PFS显著相关.
- 在 iPET 中,ΔSUVmax <72% 是唯一独立与较低的PFS相关的定量参数 (HR 5.1).
- 在iPET中DS阳性也独立预测了较低的PFS (HR 2.92),而 ΔTLG和 ΔTMTV显示为单变量但不是独立的意义.
结论:
- 在iPET中SUVmax (ΔSUVmax) 的变化是cHL中PFS的显著独立预测因子.
- 量化PET参数需要进一步调查cHL中的风险分层.
- 需要进行更大的前性研究来验证这些发现,并将定量PET纳入临床决策.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.1K
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.2K
相关概念视频
Imaging Studies II: Positron Emission Tomography and Scintigraphy
235
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
235
Positron Emission Tomography
5.5K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.5K
